Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
zMB1xKXFQUJkWjDC
Listen
